A trial of Mirabegron evaluating therapeutic efficacy and safety of directly switching from antimuscarinics to mirabegron in overactive bladder patients receiving stable antimuscarinic treatment.
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 24 Oct 2016 New trial record
- 16 Sep 2016 Results presented at the 46th Annual Meeting of the International Continence Society